| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 05/01/2007 | US7211262 Burn pain treatment by peripheral administration of a neurotoxin |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | CA2431397C Self emulsifying lipid matrix (selm) |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2326756C Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2290893C Magnesium omeprazole |
| 05/01/2007 | CA2185394C Biotinderivate |
| 04/30/2007 | CA2554701A1 Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
| 04/30/2007 | CA2554698A1 Methods of reducing alcohol-induced dose dumping for hydrocodone sustained release oral dosage forms |
| 04/30/2007 | CA2554697A1 Methods of reducing alcohol-induced dose dumping for morphine sustained release oral dosage forms |
| 04/30/2007 | CA2554684A1 Methods of reducing alcohol-induced dose dumping for oxycodone sustained release oral dosage forms |
| 04/26/2007 | WO2007047839A1 Method for treating pain |
| 04/26/2007 | WO2007047752A1 Method for treating pain |
| 04/26/2007 | WO2007047202A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | WO2007046747A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | WO2007046411A1 Method for stabilization of isoxazole compound |
| 04/26/2007 | WO2007046318A1 Liquid preparation for external application containing indomethacin |
| 04/26/2007 | WO2007046022A2 Inhibitors of phosphodiesterase type-iv |
| 04/26/2007 | WO2007045989A1 Pyridyl derivatives useful as h3 ligands |
| 04/26/2007 | WO2007045980A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | WO2007045868A1 Pyrazoles useful in the treatment of inflammation |
| 04/26/2007 | WO2007045867A1 3 -aminoindole compounds as crth2 receptor ligands |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045462A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | WO2007028256A3 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| 04/26/2007 | WO2007027477A3 Treating vulvodynia using prodrugs of gaba analogs |
| 04/26/2007 | WO2007027233A3 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid |
| 04/26/2007 | WO2007022813A3 A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 04/26/2007 | WO2006128268A8 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases |
| 04/26/2007 | WO2006123247A3 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
| 04/26/2007 | WO2006122771A3 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production |
| 04/26/2007 | WO2006053121A3 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
| 04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
| 04/26/2007 | US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | US20070092540 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof |
| 04/26/2007 | US20070092511 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 04/26/2007 | DE102005050892A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments |
| 04/26/2007 | DE102005049637A1 Antagonisten gegen die Interaktion von PF4 und RANTES Antagonists to the interaction of PF4 and RANTES |
| 04/26/2007 | CA2628577A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 04/26/2007 | CA2626628A1 Compositions of phosphodiesterase type iv inhibitors |
| 04/26/2007 | CA2626358A1 Pyrazoles useful in the treatment of inflammation |
| 04/26/2007 | CA2625762A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | CA2625189A1 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | CA2624931A1 Therapeutic agent |
| 04/25/2007 | EP1777226A1 [1,7]naphthyridines as pde4 inhibitors |
| 04/25/2007 | EP1777225A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776982A1 Pyrimidine compounds as histamine modulators |
| 04/25/2007 | EP1776367A1 Synthesis of 6,7-dihydro-5h-imidazoý1,2-a¨imidazole-3-sulfonic acid amides |
| 04/25/2007 | EP1776340A1 N-(1h-indolyl)-h-indole-2-carb0xamide derivatives, their preparation and their therapeutic use |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators |
| 04/25/2007 | EP1776106A1 Heterocyclic derivatives for modulation of calcium channels |
| 04/25/2007 | EP1776096A2 Crp lowering agent |
| 04/25/2007 | EP1430133B1 A soluble toll-like receptor |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1305037B1 Analgesic medicament |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP0984023B1 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/25/2007 | EP0949865A4 The use of cd4-binding small molecules to inhibit immune responses |
| 04/25/2007 | EP0804468B1 Method of making an omega-functionalized amino acid derivative |
| 04/25/2007 | CN2892024Y Medicated plaster |
| 04/25/2007 | CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 04/25/2007 | CN1951950A Helicid modifier and its preparation method and uses |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1951494A Compound Chinese medicinal preparation for treating affection of external wind and cold and preparation method thereof |
| 04/25/2007 | CN1951484A Oil for treating wounds |
| 04/25/2007 | CN1951483A Hybrid safflower oil and preparation method thereof |
| 04/25/2007 | CN1951462A Testing process for 'Gu Jin Wan' capsule |
| 04/25/2007 | CN1951459A Medicament for matching with holographic fire burning therapy in acupoints and preparation method thereof |
| 04/25/2007 | CN1951455A Spine applied ointment with inflammation-diminishing and pain-relieving functions |
| 04/25/2007 | CN1951450A Orally administered Chinese medicine for treating asthma complicated with fever |
| 04/25/2007 | CN1951429A Preparation process of corydalis rhizome extract and novel usage thereof |
| 04/25/2007 | CN1951412A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951411A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951395A Extraction and purification method of active constituents from stem of lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug |
| 04/25/2007 | CN1951393A Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951388A Betamethasone sodium phosphate powder injection and preparation method thereof |
| 04/25/2007 | CN1951381A Baicalin solution composition |
| 04/25/2007 | CN1951360A Complex salt crystal used for body surface physical therapy and preparation method thereof |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312176C Buthotoxin polypeptide and preparation method thereof |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/25/2007 | CN1312120C Adamantane derivatives |